Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon yesterday. The ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...

Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon today. The company’s ...

JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on ...

(Bloomberg) -- JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on private equity firms and sovereign wealth funds. Kallop is ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

William Blair also issued estimates for Vital Farms’ Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.26 EPS, FY2025 earnings at $1.28 EPS and FY2026 earnings at $1.54 EPS. Skip to main content ...

William Blair currently has a “Neutral” rating and a $14.00 price target on the stock. The consensus estimate for Intellia Therapeutics’ current full-year earnings is ($5.07) per share. Get ...